Accès libre

Counteracting poisoning with chemical warfare nerve agents

Nikolina Maček Hrvat

Nikolina Maček Hrvat

Institute for Medical Research and Occupational HealthZagreb, Croatia
Recherchez cet auteur sur
Sciendo|Google Scholar
Hrvat, Nikolina Maček
 et 
Zrinka Kovarik

Zrinka Kovarik

Institute for Medical Research and Occupational HealthZagreb, Croatia
Recherchez cet auteur sur
Sciendo|Google Scholar
Kovarik, Zrinka
  
31 déc. 2020
Counteracting poisoning with chemical warfare nerve agents's Cover Image
À propos de cet article
Article précédent
Article suivant
Citez
Télécharger la couverture
Catégorie d'article: Review
Publié en ligne: 31 déc. 2020
Pages: 266 - 284
Reçu: 01 juil. 2020
Accepté: 01 nov. 2020
DOI: https://doi.org/10.2478/aiht-2020-71-3459
Mots clés
© 2020 Nikolina Maček Hrvat, Zrinka Kovarik, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Figure 1

Representatives of the G-series (tabun, sarin, soman, cyclosarin), V-series (VX, VR), IVA agents (GV), and Novichok series (16) of nerve agents (A-230, A-232, A234, A242, A-262)
Representatives of the G-series (tabun, sarin, soman, cyclosarin), V-series (VX, VR), IVA agents (GV), and Novichok series (16) of nerve agents (A-230, A-232, A234, A242, A-262)

Figure 2

Hydrolysis of acetylcholine (A), phosphylation and aging (B), and reactivation of nerve agent-inhibited acetylcholinesterase (C)
Hydrolysis of acetylcholine (A), phosphylation and aging (B), and reactivation of nerve agent-inhibited acetylcholinesterase (C)

Figure 3

Standard pyridinium aldoxime reactivators of phosphylated acetylcholinesterase, antimuscarinic atropine, and anticonvulsant diazepam, currently approved for nerve agent poisoning therapy
Standard pyridinium aldoxime reactivators of phosphylated acetylcholinesterase, antimuscarinic atropine, and anticonvulsant diazepam, currently approved for nerve agent poisoning therapy

Figure 4

Non-oxime compounds investigated as potential treatment in case of nerve agent poisoning (120, 123)
Non-oxime compounds investigated as potential treatment in case of nerve agent poisoning (120, 123)

Figure 5

Bioscavenging of native acetylcholinesterase from inhibition with nerve agents. A) stoichiometric bioscavenging; mole-to-mole reaction between exogenous enzyme scavenger and nerve agent, B) oxime-assisted catalytic scavenging; exogenous enzyme turned into catalytic bioscavenger in the presence of an oxime enabling nerve agent degradation by cycles of inhibition and reactivation of exogenous enzyme scavenger, C) catalytic bioscavenging; low amount of exogenous enzyme scavenger rapidly hydrolyses nerve agent with a turnover
Bioscavenging of native acetylcholinesterase from inhibition with nerve agents. A) stoichiometric bioscavenging; mole-to-mole reaction between exogenous enzyme scavenger and nerve agent, B) oxime-assisted catalytic scavenging; exogenous enzyme turned into catalytic bioscavenger in the presence of an oxime enabling nerve agent degradation by cycles of inhibition and reactivation of exogenous enzyme scavenger, C) catalytic bioscavenging; low amount of exogenous enzyme scavenger rapidly hydrolyses nerve agent with a turnover

Symptoms of nerve agent poisoning arising from acetylcholine build-up at muscarinic and nicotinic membrane receptors (8, 23, 40, 41)

System Symptoms
Brain Restlessness, headache, dizziness, convulsions, inhibition of central respiratory centres, loss of consciousness, coma
Eyes Blurred vision, conjunctivitis, myosis
Respiratory Rhinorrhoea, bronchoconstriction, bronchorrhea, pulmonary oedema
Cardiovascular Either tachycardia or bradycardia, and either hypotension or hypertension
Gastro-intestinal Cramping, abdominal pain, nausea, salivation, vomiting, defecation, urinary incontinence
Muscle Twitching, fasciculation, tremors, muscle cramps, paralysis
Skin Increased sweating
Langues:
Anglais, Croatian, Slovenian
Périodicité:
4 fois par an
Sujets de la revue:
Médecine, Sciences médicales de base, Sciences médicales de base, autres
RSS Feed de la revue